These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
185 related items for PubMed ID: 20186172
1. Enhanced anti-tumor effects of combined MDR1 RNA interference and human sodium/iodide symporter (NIS) radioiodine gene therapy using an adenoviral system in a colon cancer model. Ahn SJ, Jeon YH, Lee YJ, Lee YL, Lee SW, Ahn BC, Ha JH, Lee J. Cancer Gene Ther; 2010 Jul; 17(7):492-500. PubMed ID: 20186172 [Abstract] [Full Text] [Related]
2. Human sodium iodide symporter added to multidrug resistance 1 small hairpin RNA in a single gene construct enhances the therapeutic effects of radioiodine in a nude mouse model of multidrug resistant colon cancer. Jeon YH, Ahn SJ, Lee YJ, Lee YL, Lee SW, Park SY, Kim IS, Ahn BC, Ha JH, Lee J. Cancer Biother Radiopharm; 2010 Dec; 25(6):671-9. PubMed ID: 21204761 [Abstract] [Full Text] [Related]
3. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter. Park SY, Kwak W, Thapa N, Jung MY, Nam JO, So IS, Kim SY, Yoo J, Lee J, Kim IS. J Nucl Med; 2008 Sep; 49(9):1480-8. PubMed ID: 18703598 [Abstract] [Full Text] [Related]
8. Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter. Huang R, Zhao Z, Ma X, Li S, Gong R, Kuang A. Cancer Gene Ther; 2011 Feb; 18(2):144-52. PubMed ID: 21037556 [Abstract] [Full Text] [Related]
9. In vivo long-term imaging and radioiodine therapy by sodium-iodide symporter gene expression using a lentiviral system containing ubiquitin C promoter. Kim HJ, Jeon YH, Kang JH, Lee YJ, Kim KI, Chung HK, Jeong JM, Lee DS, Lee MC, Chung JK. Cancer Biol Ther; 2007 Jul; 6(7):1130-5. PubMed ID: 17611400 [Abstract] [Full Text] [Related]
11. Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer. Trujillo MA, Oneal MJ, Davydova J, Bergert E, Yamamoto M, Morris JC. Breast Cancer Res; 2009 Jul; 11(4):R53. PubMed ID: 19635153 [Abstract] [Full Text] [Related]
12. Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene. Kim YH, Youn H, Na J, Hong KJ, Kang KW, Lee DS, Chung JK. Theranostics; 2015 Jul; 5(1):86-96. PubMed ID: 25553100 [Abstract] [Full Text] [Related]
13. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells. Li W, Tan J, Wang P, Wu P. Cancer Biother Radiopharm; 2011 Aug; 26(4):443-51. PubMed ID: 21797672 [Abstract] [Full Text] [Related]
18. Tumor-targeted radionuclide imaging and therapy based on human sodium iodide symporter gene driven by a modified telomerase reverse transcriptase promoter. Kim SH, Chung HK, Kang JH, Kim KI, Jeon YH, Jin YN, Yun CO, Chung JK. Hum Gene Ther; 2008 Sep; 19(9):951-7. PubMed ID: 18810799 [Abstract] [Full Text] [Related]
19. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter. Petrich T, Helmeke HJ, Meyer GJ, Knapp WH, Pötter E. Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124 [Abstract] [Full Text] [Related]
20. [Radioiodide treatment mediated by adenovirus transfer of human sodium iodide symporter gene into androgen-independent prostate cancer]. Huang R, Ma X, Li S, Mu D, Gong R, Kuang A. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Oct; 27(5):1080-4. PubMed ID: 21089675 [Abstract] [Full Text] [Related] Page: [Next] [New Search]